BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30135250)

  • 41. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.
    Ryoo YW; Kim BC; Lee KS
    J Dermatol Sci; 2001 Jun; 26(2):125-32. PubMed ID: 11378329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J
    Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
    Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
    Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells.
    Gruber C; Gratz IK; Murauer EM; Mayr E; Koller U; Bruckner-Tuderman L; Meneguzzi G; Hintner H; Bauer JW
    Mol Cancer Ther; 2011 Feb; 10(2):233-41. PubMed ID: 21209069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
    Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
    Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
    Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
    Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational founder effect in recessive dystrophic epidermolysis bullosa families from Southern Tunisia.
    Ben Brick AS; Laroussi N; Mesrati H; Kefi R; Bchetnia M; Lasram K; Ben Halim N; Romdhane L; Ouragini H; Marrakchi S; Boubaker MS; Meddeb Cherif M; Castiglia D; Hovnanian A; Abdelhak S; Turki H
    Arch Dermatol Res; 2014 May; 306(4):405-11. PubMed ID: 24170138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.
    Saeidian AH; Youssefian L; Moreno Trevino MG; Fortuna G; Vahidnezhad H; Atanasova VS; Uitto J; Salas-Alanis JC; South AP
    Clin Exp Dermatol; 2018 Jul; 43(5):579-584. PubMed ID: 29473190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
    Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D
    Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of skin cancers in epidermolysis bullosa.
    Venugopal SS; Murrell DF
    Dermatol Clin; 2010 Apr; 28(2):283-7, ix-x. PubMed ID: 20447493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma.
    Lee CAA; Wu S; Chow YT; Kofman E; Williams V; Riddle M; Eide C; Ebens CL; Frank MH; Tolar J; Hook KP; AlDubayan SH; Frank NY
    J Invest Dermatol; 2024 Jan; ():. PubMed ID: 38272206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HPV Meets APOBEC: New Players in Head and Neck Cancer.
    Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma.
    Tamura R; Nakaoka H; Yachida N; Ueda H; Ishiguro T; Motoyama T; Inoue I; Enomoto T; Yoshihara K
    Cancer Sci; 2023 May; 114(5):2145-2157. PubMed ID: 36762791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa.
    Cianfarani F; Zambruno G; Castiglia D; Odorisio T
    Am J Pathol; 2017 Jul; 187(7):1445-1453. PubMed ID: 28460207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
    Newman C; Wagner RF; Tyring SK; Spigel GT
    J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotype-phenotype correlation in italian patients with dystrophic epidermolysis bullosa.
    Gardella R; Castiglia D; Posteraro P; Bernardini S; Zoppi N; Paradisi M; Tadini G; Barlati S; McGrath JA; Zambruno G; Colombi M
    J Invest Dermatol; 2002 Dec; 119(6):1456-62. PubMed ID: 12485454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
    Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
    Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Duong T; Wong D; Barrett A; Price H
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33637494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.